申请人:Hoffmann-La Roche Inc.
公开号:US06380387B1
公开(公告)日:2002-04-30
Compounds of Formula I are disclosed,
having activity as inhibitors of binding between VCAM-1 and cells expressing VLA-4, and accordingly useful for treating diseases whose symptoms and or damage are related to the binding of VCAM-1 to cells expressing VLA-4.
公式I的化合物被披露,具有作为VCAM-1和表达VLA-4的细胞之间结合抑制剂的活性,因此可用于治疗症状和/或损害与VCAM-1与表达VLA-4的细胞结合相关的疾病。